Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase versus alteplase for acute ischaemic stroke
ACTRN12613000243718Phase 3Terminated
- Sponsor
- Acute Stroke Service
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
Phase 3, randomised, open-label trial in brain infarction comparing Tenecteplase with Alteplase (2 arms). Primary endpoint: Modified Rankin Scale 0-1 at 3 months. Started Mar 2014; status: terminated.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12613000243718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000243718.